Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that detect early signs of oral cancer and throat cancer.
The FDA designation validates the technology used in Viome’s at-home Health Intelligence Test that analyzes users’ microbial, human and mitochondrial...
Using longitudinal temperature data, wearable devices can predict the onset of illnesses even without recognizable symptoms, according to new research published in Scientific Reports.
The paper included data from only 50 participants, and researchers stressed that the findings are a proof-of-concept effort, suggesting the need for further research into the role of wearable sensors in early...
Symptom-based COVID-19 screening can be improved by incorporating data collected from wearable sensors into prediction algorithms, an approach that could complement ongoing testing efforts by spotting symptomatic and pre-symptomatic individuals early, according to a research letter recently published in nature medicine.
The findings are part of the DETECT (Digital Engagement and Tracking for...
Fitbit may be able to detect COVID-19 in patients before they start to feel symptoms, based on early findings from the company’s “Assessment of physiological signs associated with COVID-19 measured using wearable devices” preprint study.
The study includes preliminary data that has yet to be peer reviewed by a medical journal.
With the research gathered in its study, Fitbit hopes to create an...